Maximum Views Reached

You have reached the maximum number of Guideline views for today. By creating a free account, you can increase your number of complimentary daily views.

To view this Guideline, please log in to your account. If you do not have an account, you can create one for free by clicking the button below.

Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults

Publication Date: December 13, 2021

Last Updated: September 2, 2022

Treatment

IDH-mutant Astrocytic and Oligodendroglial Tumors

Oligodendroglioma, IDH-mutant, 1p/19q co-deleted, CNS WHO grade 2

Recommendation 1.1

People with oligodendroglioma, IDH-mutant, 1p/19q co-deleted, CNS WHO grade 2 should be offered radiation in combination with PCV. ( EB , I , B , S )

3336

Temozolomide is a reasonable alternative to PCV when toxicity is a concern. ( IC , L , , W )

Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults

Treatment

IDH-mutant Astrocytic and Oligodendroglial Tumors

Oligodendroglioma, IDH-mutant, 1p/19q co-deleted, CNS WHO grade 2

Recommendation 1.1

Overview

Title

Authoring Organization